The Moderna Laboratory has begun the so-called phase 1 trial stage of an HIV vaccine using messenger RNA technology in the United States, on 56 uninfected adults, both the biotech company and the ...

Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of its candidate HIV vaccine in Africa, where the burden of the virus is still being keenly felt.

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Funds have also been suspended for AIDS Clinical Trial Group, a nearly 40-year-old system that has been responsible for key ...

Africa bears a disproportionate infectious disease burden, with HIV, tuberculosis, and malaria posing ongoing threats ...

Moderna stock has dropped more than 70% over the past year. The company’s coronavirus vaccine no longer is driving outsized growth -- and Moderna is still in the process of ushering in newer ...

There’s also ongoing work on a potential HIV vaccine. To find out more about HIV drugs that are currently available (and those that may become available in the future), talk with a healthcare ...

Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of ...

In the final days of President Joe Biden’s term, Moderna MRNA won the $590 million contract to use its mRNA vaccine technology for a bird-flu vaccine. Back To Top ...